Frontiers in Oncology | Breast Cancer

Case Report

Published on 26 Nov 2025

Dual malignancies: a case report of the sequential occurrence of a trichilemmal tumor and breast carcinoma in a 56-year-old female

in Breast Cancer

Bhargav Vuppumalla
A. Ravichandran
M. Manickavasagam
Chaitanya Kumar Javvaji
Keta Vagha

Frontiers in Oncology

doi 10.3389/fonc.2025.1590725

977 views

Original Research

Published on 26 Nov 2025

Patterns of response of breast cancer after neoadjuvant chemotherapy according to molecular subtype

in Breast Cancer

Malak Ghezzawi
Mohamad Hadi El Charif
Lynn Lteif
Vahe Panossian
Anthony Haddad
Sali Sarkis
Yara Zebian
Mira Kheil
Mohammad Ali Maktabi
Najla Fakhruddin

Frontiers in Oncology

doi 10.3389/fonc.2025.1670594

1,210 views

Case Report

Published on 25 Nov 2025

A case report of multiple primary malignant tumors: breast cancer and colorectal cancer

in Breast Cancer

Mirinisa Kaicaier
Shengjie Liu
Yuhan Zhang
Xueping Hou
Yuying Wang
Aisaide Aikelaimu
Liyuan Ma
Weihua Jiang

Frontiers in Oncology

doi 10.3389/fonc.2025.1713186

1,059 views
1 citation

Original Research

Accepted on 24 Nov 2025

Patient-Derived Cell Lines Unveil COL1A2 as a Predictor of Docetaxel Resistance in Breast Cancer

in Breast Cancer

Yuwei Gao
Rong Wang
Xiaowei Dou
Chen Song
Wenhao Chen
Jinting Liu
Suo Zhu
Jianjun Huang
Qingjun Gao

Frontiers in Oncology

304 views

Original Research

Published on 24 Nov 2025

Caprine herpes virus-1 reduces cell viability and enhances chemosensitivity in breast cancer cells

in Breast Cancer

C. A. Iannuzzi
F. Pagano
M. Tomeo
A. Sfera
A. Calabrese
L. Alfano
R. Carmerlingo
S. Cocco
S. Damiano
Serena Montagnaro

Frontiers in Oncology

doi 10.3389/fonc.2025.1676296

1,252 views

Original Research

Published on 21 Nov 2025

Nomogram for predicting risk of arm lymphedema following axillary lymph node dissection in breast cancer patients

in Breast Cancer

Miaomiao Jia
Lihui Pan
Haibo Yang
Jinnan Gao
Wenzhuang Shen
Xiaojun Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1667939

1,112 views

Original Research

Published on 21 Nov 2025

Deviating HER2 status between primary breast carcinomas and their liver metastases

in Breast Cancer

Yuexia Chen
Liu Yang
Wei Qu
Jianhong Tu
Suqing Cheng
Xingmei Guo

Frontiers in Oncology

doi 10.3389/fonc.2025.1723716

966 views

Case Report

Published on 20 Nov 2025

A case report of tumor-associated liver injury alleviated with antineoplastic drug

in Breast Cancer

ZiRu Yang
Lixia Cao
Wentao Kuai
Shengjuan Yao
Shuang Li
Liang Xu

Frontiers in Oncology

doi 10.3389/fonc.2025.1644790

1,120 views

Systematic Review

Published on 20 Nov 2025

Association between hysterectomy for benign indications and the risk of breast cancer: a systematic review and meta- analysis

in Breast Cancer

Wenjing Liu
Tingting Lu
Jingqi Yang
Jie Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1600459

1,112 views

Original Research

Published on 17 Nov 2025

Assessment of the efficacy of various neoadjuvant anti-HER2 targeted therapies combined with chemotherapy for HER2-positive breast cancer in the real-world setting and development of a predictive model for pathological complete response

in Breast Cancer

Haoqi Wang
Shan Gao
Zihao Bai
Lijia Wang
Cuizhi Geng

Frontiers in Oncology

doi 10.3389/fonc.2025.1673810

1,494 views

Original Research

Published on 17 Nov 2025

Real-world data analysis of adjuvant capecitabine for triple-negative breast cancer after neoadjuvant chemotherapy

in Breast Cancer

Ana Godoy-Ortíz
Gonzalo Lendínez-Sánchez
Manuel Zalabardo
Javier Pascual
Ana López-Pascual
Alexandra Cantero
Nuria Ribelles
Marcos Iglesias
Ester Villar
Bella Pajares

Frontiers in Oncology

doi 10.3389/fonc.2025.1648272

1,566 views

Original Research

Published on 17 Nov 2025

Aberrant sialic acid metabolism promotes metabolic reprogramming and metastasis in breast cancer

in Breast Cancer

Longyu Yang
Zhenhua Li
Meijin Wang
Xing Xiong
Shilin Zhang
Zhi Man
Chunyan Dong
Li Fu

Frontiers in Oncology

doi 10.3389/fonc.2025.1698087

1,315 views

Original Research

Published on 13 Nov 2025

Breast cancer burden in the United States (1990–2021) with a 15-year forecast: a comprehensive analysis based on the global burden of disease 2021

in Breast Cancer

Zhijian Huang
Lingxiao Zhang
Peizhang Liu
Hongxiang Lin
Zeyi Peng
Peixin Zheng
Xinhao Sun
Lisheng Lin

Frontiers in Oncology

doi 10.3389/fonc.2025.1650110

1,785 views

Correction

Published on 11 Nov 2025

Correction: Abemaciclib early access - an Italian experience

in Breast Cancer

Concetta Calabrò
Eleonora Cannella
Patrizia Nardulli

Frontiers in Oncology

doi 10.3389/fonc.2025.1734231

468 views

Original Research

Published on 11 Nov 2025

Evaluating metastatic risk in breast cancer through CTCs and L1CAM expression

in Breast Cancer

Ni Liao
Qiong Guo
Jingjing Chen
Fulan Tan
Yan Huang
Jiansheng Yi
Yi Hu
Chen Zeng
Qianhui Ouyang
Zhouxi Chen

Frontiers in Oncology

doi 10.3389/fonc.2025.1686166

1,249 views

Mini Review

Published on 10 Nov 2025

Circulating DNA tumor fraction as a biomarker for advanced breast cancer

in Breast Cancer

Emily Cybulla
Daniel G. Stover

Frontiers in Oncology

doi 10.3389/fonc.2025.1655415

1,824 views
1 citation

Editorial

Published on 07 Nov 2025

Editorial: Case reports in breast cancer 2023-2024

in Breast Cancer

Fengting Yan
Min Sun
Henry Kaplan

Frontiers in Oncology

doi 10.3389/fonc.2025.1711001

1,546 views

Original Research

Published on 07 Nov 2025

Establishment and validation of a prognostic risk model based on ADME-related genes in breast cancer

in Breast Cancer

Yang Yang
Lei Yan
Yang Feng
Yuling Liu
Guangmin Shi
Jiqing Hao

Frontiers in Oncology

doi 10.3389/fonc.2025.1568379

1,171 views

Correction

Published on 07 Nov 2025

Correction: Comparative study on bone mineral density in premenopausal patients with estrogen receptor-positive breast cancer in ASTRRA Study: a 5-year follow-up study

in Breast Cancer

Eunju Shin
Seung Il Kim
Min-ho Park
Hyun-Ah Kim
Yongsik Jung
Jai Min Ryu
Eun Hwa Park
Sung Yong Kim
Eun-Gyeong Lee
Min Hyuk Lee

Frontiers in Oncology

doi 10.3389/fonc.2025.1729229

643 views

Original Research

Published on 07 Nov 2025

Unveiling the traits of HER2-low breast cancer: a comparative analysis of IHC1+ vs IHC2+/ISH-negative subgroups – insights from a 3-year cohort study

in Breast Cancer

Jorge Correia
Catarina Pulido
Joana Albuquerque
Gil Prazeres
Inês Margarido
Mariana Câmara
Rita Neto
Gonçalo Fernandes
João Godinho
Mónica Nave

Frontiers in Oncology

doi 10.3389/fonc.2025.1675075

1,581 views

Original Research

Published on 06 Nov 2025

CDK1 may promote breast cancer progression through AKT activation and immune modulation

in Breast Cancer

Huanhong Zeng
Minxue Zhuang
Bochuan Liang
Feili Cai
Mengbo Lin
Ruijuan Wang
Ruo Wang
Hui Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1591706

1,518 views

Review

Published on 05 Nov 2025

The role of lactylation in breast cancer development: mechanisms, clinical translation and new strategies for treatment

in Breast Cancer

Yanzhen Lu
Xiaoting Yang
Lulu Tan
Yunfei Yang
Dan Yu
Gang Feng
Yuyan Tan

Frontiers in Oncology

doi 10.3389/fonc.2025.1665097

2,420 views

Case Report

Published on 03 Nov 2025

Tall cell carcinoma with reversed polarity of breast cancer: a rare case report and review of the literature

in Breast Cancer

Wenqi Duan
Longmei Zhang
Jinqi Gao
Zhe Wang
Mengjie Ren
Huajian Wu
Ya Deng
Chunlong Guo
Jianing Jiang

Frontiers in Oncology

doi 10.3389/fonc.2025.1635976

1,268 views

Systematic Review

Published on 30 Oct 2025

Primary breast leiomyosarcoma: prognostic factors and treatment outcomes – a systematic review and case report (1969–2023)

in Breast Cancer

Rui Guo
Weiwei Zhang
Xingli Ji
Xiaohu Liu
Lang He

Frontiers in Oncology

doi 10.3389/fonc.2025.1662132

1,230 views

1,708 articles

articles

Dual malignancies: a case report of the sequential occurrence of a trichilemmal tumor and breast carcinoma in a 56-year-old female

Patterns of response of breast cancer after neoadjuvant chemotherapy according to molecular subtype

A case report of multiple primary malignant tumors: breast cancer and colorectal cancer

Patient-Derived Cell Lines Unveil COL1A2 as a Predictor of Docetaxel Resistance in Breast Cancer

Caprine herpes virus-1 reduces cell viability and enhances chemosensitivity in breast cancer cells

Nomogram for predicting risk of arm lymphedema following axillary lymph node dissection in breast cancer patients

Deviating HER2 status between primary breast carcinomas and their liver metastases

A case report of tumor-associated liver injury alleviated with antineoplastic drug

Association between hysterectomy for benign indications and the risk of breast cancer: a systematic review and meta- analysis

Assessment of the efficacy of various neoadjuvant anti-HER2 targeted therapies combined with chemotherapy for HER2-positive breast cancer in the real-world setting and development of a predictive model for pathological complete response

Real-world data analysis of adjuvant capecitabine for triple-negative breast cancer after neoadjuvant chemotherapy

Aberrant sialic acid metabolism promotes metabolic reprogramming and metastasis in breast cancer

Breast cancer burden in the United States (1990–2021) with a 15-year forecast: a comprehensive analysis based on the global burden of disease 2021

Correction: Abemaciclib early access - an Italian experience

Evaluating metastatic risk in breast cancer through CTCs and L1CAM expression

Circulating DNA tumor fraction as a biomarker for advanced breast cancer

Editorial: Case reports in breast cancer 2023-2024

Establishment and validation of a prognostic risk model based on ADME-related genes in breast cancer

Correction: Comparative study on bone mineral density in premenopausal patients with estrogen receptor-positive breast cancer in ASTRRA Study: a 5-year follow-up study

Unveiling the traits of HER2-low breast cancer: a comparative analysis of IHC1+ vs IHC2+/ISH-negative subgroups – insights from a 3-year cohort study

CDK1 may promote breast cancer progression through AKT activation and immune modulation

The role of lactylation in breast cancer development: mechanisms, clinical translation and new strategies for treatment

Tall cell carcinoma with reversed polarity of breast cancer: a rare case report and review of the literature

Primary breast leiomyosarcoma: prognostic factors and treatment outcomes – a systematic review and case report (1969–2023)